News

WE’RE living through a back pain epidemic.  It affects 49million people in the UK and 619million globally, and it can wreak ...
Researchers have observed a mechanism in the brain that may ‘pump the brakes’ on acute pain to prevent overload while not inhibiting chronic pain at all.
But in some autoimmune diseases, such as type 1 diabetes, people have antibodies that react to molecules within their own body, called auto-antibodies, which contribute to the pain and inflammation.
Studies are now underway that could help Journavx win additional FDA approvals for some kinds of chronic pain. Vertex says it is specifically studying Journavx in patients with diabetic peripheral ...
— -- Question: Why Do Some Over-The-Counter Pain Killers Contain Caffeine, And Is That A Good Thing? Answer: Another question that comes up commonly is about the role of caffeine.Caffeine is ...
In a small Phase 2 study presented at the 53rd American Society of Hematology's Annual Meeting and Exposition, once-daily prasugrel 5mg for 30 days showed some promise of decreasing pain in ...
It's offered hope for the 1 in 5 Americans who suffer from chronic pain, but it's also just out of reach. Journavx is the first new kind of painkiller in more than 20 years, and the medical ...
It's a pill for severe acute pain that works by blocking plain signals from where someone hurts. It's offered hope for the 1 in 5 Americans who suffer from chronic pain, but it's also just out of ...